Concepedia

Jakob Loschko

JL

Statistics

Publications

22

Citations

4.8K

H-Index

21

Active since

2011

Affiliations

Rockefeller University(Current)

Pfizer (United States)

The University of Texas Medical Branch at Galveston

BioNTech (Germany)

Johannes Gutenberg University Mainz

Jakob Loschko is an author at Rockefeller University specializing in immunology, medicine, and autoimmunity.

Top concepts

Publications per year

2011–2022

22

Publications

22

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

, , +7

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Annette B. Vogel, Isis Kanevsky, Ye Che et al. · Nature · 2021 · 725 citations · Full text

, , +4

Classical dendritic cells are required for dietary antigen–mediated induction of peripheral Treg cells and tolerance

Daria Esterházy, Jakob Loschko, Mariya London et al. · Nature Immunology · 2016 · 300 citations · Full text

, , +15

The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells

Shinelle Menezes, Daisy Melandri, Giorgio Anselmi et al. · Immunity · 2016 · 282 citations · Full text

Intestinal monocytes and macrophages are required for T cell polarization in response to <i>Citrobacter rodentium</i>

Heidi A. Schreiber, Jakob Loschko, Roos A. Karssemeijer et al. · The Journal of Experimental Medicine · 2013 · 189 citations · Full text

1–5 of 22